Chiti A - Search Results

1

PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence.

Lopci E, Grassi I, Chiti A, Nanni C, Cicoria G, Toschi L, Fonti C, Lodi F, Mattioli S, Fanti S. Lopci E, et al. Among authors: chiti a. Am J Nucl Med Mol Imaging. 2014 Jun 7;4(4):365-84. eCollection 2014. Am J Nucl Med Mol Imaging. 2014. PMID: 24982822 Free PMC article. Review.

2

Somatostatin receptor scintigraphy in a patient with an epigastric mass and multiple liver metastases.

Fanti S, Bellanova B, Chiti A, Romeo A, Petronelli A, Panetta A, Martoni A, Bertoni F, Bombardieri E, Monetti N. Fanti S, et al. Among authors: chiti a. Clin Nucl Med. 1997 Nov;22(11):802-3. doi: 10.1097/00003072-199711000-00024. Clin Nucl Med. 1997. PMID: 9363403 No abstract available.

3

Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours.

Chiti A, Fanti S, Savelli G, Romeo A, Bellanova B, Rodari M, van Graafeiland BJ, Monetti N, Bombardieri E. Chiti A, et al. Eur J Nucl Med. 1998 Oct;25(10):1396-403. doi: 10.1007/s002590050314. Eur J Nucl Med. 1998. PMID: 9818279 Clinical Trial.

4

Results and potential of somatostatin receptor imaging in gastroenteropancreatic tract tumours.

Chiti A, Briganti V, Fanti S, Monetti N, Masi R, Bombardieri E. Chiti A, et al. Q J Nucl Med. 2000 Mar;44(1):42-9. Q J Nucl Med. 2000. PMID: 10932600

5

Somatostatin receptor scintigraphy for bronchial carcinoid follow-up.

Fanti S, Farsad M, Battista G, Monetti F, Montini GC, Chiti A, Savelli G, Petrella F, Bini A, Nanni C, Romeo A, Franchi R, Bombardieri E, Canini R, Monetti N. Fanti S, et al. Among authors: chiti a. Clin Nucl Med. 2003 Jul;28(7):548-52. doi: 10.1097/00003072-200307000-00003. Clin Nucl Med. 2003. PMID: 12819406 Clinical Trial.

6

Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE.

Virgolini I, Ambrosini V, Bomanji JB, Baum RP, Fanti S, Gabriel M, Papathanasiou ND, Pepe G, Oyen W, De Cristoforo C, Chiti A. Virgolini I, et al. Among authors: chiti a. Eur J Nucl Med Mol Imaging. 2010 Oct;37(10):2004-10. doi: 10.1007/s00259-010-1512-3. Eur J Nucl Med Mol Imaging. 2010. PMID: 20596866

7

Matched pairs dosimetry: 124I/131I metaiodobenzylguanidine and 124I/131I and 86Y/90Y antibodies.

Lopci E, Chiti A, Castellani MR, Pepe G, Antunovic L, Fanti S, Bombardieri E. Lopci E, et al. Among authors: chiti a. Eur J Nucl Med Mol Imaging. 2011 May;38 Suppl 1:S28-40. doi: 10.1007/s00259-011-1772-6. Epub 2011 Apr 12. Eur J Nucl Med Mol Imaging. 2011. PMID: 21484381 Review.

8

[11C]-choline PET/CT in imaging locally advanced prostate cancer.

Rodari M, Lopci E, Pepe G, Antunovic L, Chiti A. Rodari M, et al. Among authors: chiti a. Nucl Med Rev Cent East Eur. 2011;14(2):118-9. doi: 10.5603/nmr.2011.00028. Nucl Med Rev Cent East Eur. 2011. PMID: 22219155 Free article.

9

FDG PET/CT predictive role in follicular lymphoma.

Lopci E, Zanoni L, Chiti A, Fonti C, Santi I, Zinzani PL, Fanti S. Lopci E, et al. Among authors: chiti a. Eur J Nucl Med Mol Imaging. 2012 May;39(5):864-71. doi: 10.1007/s00259-012-2079-y. Epub 2012 Feb 22. Eur J Nucl Med Mol Imaging. 2012. PMID: 22354449

10

Somatostatin receptor SPECT.

Pepe G, Moncayo R, Bombardieri E, Chiti A. Pepe G, et al. Among authors: chiti a. Eur J Nucl Med Mol Imaging. 2012 Feb;39 Suppl 1:S41-51. doi: 10.1007/s00259-011-2019-2. Eur J Nucl Med Mol Imaging. 2012. PMID: 22388628 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

438 results

Search Page

Filters